LIOTHYRONINE SODIUM

LIOTHYRONINE SODIUM was reported 8769 times

These side effects are most commonly reported by patients taking LIOTHYRONINE SODIUM:

# Side effect Count
0 DRUG INEFFECTIVE 969
1 HEADACHE 887
2 FATIGUE 860
3 NAUSEA 587
4 DYSPNOEA 562
5 PAIN 491
6 HYPERTENSION 471
7 MALAISE 451
8 WEIGHT INCREASED 443
9 HYPOTHYROIDISM 433
10 FEELING ABNORMAL 420
11 DIZZINESS 402
12 DIARRHOEA 390
13 OFF LABEL USE 377
14 INSOMNIA 361
15 ASTHMA 360
16 GASTROOESOPHAGEAL REFLUX DISEASE 353
17 ASTHENIA 338
18 ANXIETY 336
19 BURNING SENSATION 336
20 ARTHRALGIA 333
21 FIBROMYALGIA 329
22 CARDIAC DISORDER 326
23 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 325
24 DEPRESSION 320
25 SLEEP APNOEA SYNDROME 315
26 ALOPECIA 309
27 WEIGHT DECREASED 301
28 CARPAL TUNNEL SYNDROME 285
29 BLOOD TEST ABNORMAL 274
30 RHINITIS ALLERGIC 264
31 PALPITATIONS 263
32 POLYCYSTIC OVARIES 262
33 SENSITISATION 260
34 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 257
35 RENAL DISORDER 256
36 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 256
37 VOMITING 255
38 WHEEZING 237
39 RASH 235
40 PRURITUS 234
41 FALL 231
42 PAIN IN EXTREMITY 229
43 CONDITION AGGRAVATED 219
44 EJECTION FRACTION 211
45 COUGH 201
46 TREMOR 201
47 CONSTIPATION 200
48 DRUG HYPERSENSITIVITY 198
49 MUSCLE SPASMS 196
50 SOMNOLENCE 193
51 PRODUCT DOSE OMISSION ISSUE 189
52 BACK PAIN 184
53 MYALGIA 178
54 HYPERSENSITIVITY 175
55 SINUSITIS 173
56 MIGRAINE 166
57 PARAESTHESIA 165
58 CHEST PAIN 164
59 URTICARIA 164
60 ABDOMINAL PAIN UPPER 158
61 ABDOMINAL DISTENSION 157
62 HEART RATE INCREASED 157
63 HYPERHIDROSIS 157
64 PYREXIA 154
65 GAIT DISTURBANCE 152
66 BLOOD PRESSURE INCREASED 151
67 URINARY TRACT INFECTION 146
68 ABDOMINAL DISCOMFORT 141
69 COVID-19 141
70 INJECTION SITE PAIN 141
71 HOSPITALISATION 137
72 ILLNESS 137
73 NASOPHARYNGITIS 137
74 ABDOMINAL PAIN 132
75 DECREASED APPETITE 126
76 PERIPHERAL SWELLING 126
77 VISION BLURRED 125
78 HYPOAESTHESIA 124
79 PRODUCT QUALITY ISSUE 120
80 CHEST DISCOMFORT 118
81 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 115
82 INTENTIONAL PRODUCT USE ISSUE 115
83 SUICIDAL IDEATION 113
84 MUSCULAR WEAKNESS 111
85 PRODUCT SUBSTITUTION ISSUE 110
86 OEDEMA PERIPHERAL 106
87 DEATH 105
88 PNEUMONIA 105
89 ERYTHEMA 104
90 DYSPEPSIA 101
91 CONFUSIONAL STATE 100
92 MEMORY IMPAIRMENT 100
93 DRY MOUTH 98
94 ADVERSE EVENT 94
95 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 94
96 INFECTION 93
97 PRODUCT USE ISSUE 91
98 INCORRECT DOSE ADMINISTERED 90
99 HYPOTENSION 88
100 MUSCULOSKELETAL STIFFNESS 88
101 SWELLING 88
102 BLOOD GLUCOSE INCREASED 87
103 FLUSHING 87
104 GASTROINTESTINAL DISORDER 87
105 THERAPEUTIC RESPONSE UNEXPECTED 87
106 JOINT SWELLING 86
107 DRUG INTOLERANCE 85
108 DRY SKIN 85
109 NEPHRECTOMY 85
110 EYE PAIN 84
111 INFLUENZA 84
112 OROPHARYNGEAL PAIN 84
113 EJECTION FRACTION ABNORMAL 83
114 THYROID DISORDER 82
115 CHILLS 81
116 PRODUCT USE IN UNAPPROVED INDICATION 81
117 ANAEMIA 80
118 ARTHRITIS 80
119 UNEVALUABLE EVENT 80
120 VISUAL IMPAIRMENT 80
121 BLOOD THYROID STIMULATING HORMONE DECREASED 79
122 DEHYDRATION 77
123 HYPERTHYROIDISM 76
124 STRESS 76
125 BLOOD THYROID STIMULATING HORMONE INCREASED 75
126 NEUROPATHY PERIPHERAL 74
127 PRE-EXISTING CONDITION IMPROVED 73
128 INFLUENZA LIKE ILLNESS 72
129 NECK PAIN 72
130 BRONCHITIS 70
131 DISTURBANCE IN ATTENTION 70
132 IRRITABILITY 70
133 LETHARGY 70
134 FULL BLOOD COUNT ABNORMAL 69
135 OSTEOARTHRITIS 69
136 BALANCE DISORDER 67
137 INTENTIONAL PRODUCT MISUSE 67
138 LOSS OF CONSCIOUSNESS 67
139 RHEUMATOID ARTHRITIS 67
140 ATRIAL FIBRILLATION 66
141 NERVOUSNESS 66
142 TACHYCARDIA 65
143 CONTUSION 63
144 HYPERSOMNIA 63
145 OEDEMA 63
146 TINNITUS 63
147 BLOOD PRESSURE DECREASED 62
148 DYSPHAGIA 62
149 OBSTRUCTIVE SLEEP APNOEA SYNDROME 62
150 OVERDOSE 62
151 SLEEP DISORDER 62
152 DRY EYE 61
153 EYE SWELLING 61
154 HOT FLUSH 61
155 SWELLING FACE 60
156 THYROID FUNCTION TEST ABNORMAL 60
157 NASAL CONGESTION 59
158 DRUG INTERACTION 58
159 EMOTIONAL DISTRESS 58
160 FEELING COLD 58
161 FLUID RETENTION 58
162 SYNCOPE 58
163 COELIAC DISEASE 57
164 PRODUCTIVE COUGH 57
165 AMNESIA 56
166 DYSPHONIA 56
167 FEELING HOT 56
168 SEIZURE 56
169 DIABETES MELLITUS 54
170 PANIC ATTACK 54
171 SURGERY 54
172 AGITATION 53
173 AUTOIMMUNE THYROIDITIS 53
174 THROAT IRRITATION 53
175 INJECTION SITE ERYTHEMA 52
176 REACTION TO EXCIPIENT 52
177 VERTIGO 52
178 CHRONIC KIDNEY DISEASE 51
179 DYSGEUSIA 51
180 FLATULENCE 51
181 INJURY 51
182 RENAL FAILURE 51
183 WHITE BLOOD CELL COUNT DECREASED 51
184 DEPRESSED MOOD 49
185 MOBILITY DECREASED 48
186 EYE IRRITATION 47
187 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 47
188 BONE PAIN 46
189 DRUG EFFECT DECREASED 46
190 MYOCARDIAL INFARCTION 46
191 NEPHROLITHIASIS 46
192 NEPHROPATHY 45
193 NEUTROPENIA 45
194 COGNITIVE DISORDER 44
195 DRUG DOSE OMISSION 44
196 DEEP VEIN THROMBOSIS 43
197 DRUG WITHDRAWAL SYNDROME 43
198 POLLAKIURIA 43
199 ROAD TRAFFIC ACCIDENT 43
200 SEASONAL ALLERGY 43
201 SEPSIS 43
202 SKIN EXFOLIATION 43
203 DISEASE RECURRENCE 42
204 INFUSION RELATED REACTION 42
205 BLOOD CHOLESTEROL INCREASED 41
206 CEREBROVASCULAR ACCIDENT 41
207 FEELING JITTERY 41
208 HAEMORRHAGE 41
209 MUSCULOSKELETAL PAIN 41
210 OSTEOPOROSIS 41
211 OXYGEN SATURATION DECREASED 41
212 RHINORRHOEA 41
213 SPEECH DISORDER 41
214 STOMATITIS 41
215 CATARACT 40
216 LABORATORY TEST ABNORMAL 40
217 SEDATION 40
218 HEART RATE DECREASED 39
219 HEPATIC ENZYME INCREASED 39
220 PULMONARY EMBOLISM 39
221 TRI-IODOTHYRONINE DECREASED 39
222 ACUTE KIDNEY INJURY 38
223 BREAST CANCER 38
224 DISCOMFORT 38
225 EAR INFECTION 38
226 CRYING 37
227 THROAT TIGHTNESS 37
228 TRI-IODOTHYRONINE INCREASED 37
229 ECZEMA 36
230 EPISTAXIS 36
231 MENTAL DISORDER 36
232 PSORIASIS 36
233 ANGER 35
234 BLOOD THYROID STIMULATING HORMONE ABNORMAL 35
235 DEVICE ISSUE 35
236 NIGHT SWEATS 35
237 UPPER RESPIRATORY TRACT INFECTION 35
238 ABNORMAL DREAMS 34
239 ADVERSE DRUG REACTION 34
240 BLISTER 34
241 INJECTION SITE PRURITUS 34
242 REACTION TO DRUG EXCIPIENTS 34
243 TENDONITIS 34
244 TREATMENT NONCOMPLIANCE 34
245 WITHDRAWAL SYNDROME 34
246 ACTIVITIES OF DAILY LIVING IMPAIRED 33
247 EAR PAIN 33
248 EATING DISORDER 33
249 GENERAL PHYSICAL HEALTH DETERIORATION 33
250 HAEMOGLOBIN DECREASED 33
251 HERPES ZOSTER 33
252 PRODUCT ADMINISTRATION INTERRUPTED 33
253 PSYCHOMOTOR HYPERACTIVITY 33
254 SWOLLEN TONGUE 33
255 THERAPEUTIC PRODUCT EFFECT DECREASED 33
256 DYSSTASIA 32
257 INJECTION SITE BRUISING 32
258 INJECTION SITE SWELLING 32
259 NO ADVERSE EVENT 32
260 OCULAR HYPERAEMIA 32
261 PRODUCT DISPENSING ERROR 32
262 THROMBOSIS 32
263 HEART RATE IRREGULAR 31
264 HEAD INJURY 30
265 HYPOGLYCAEMIA 30
266 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30
267 INFLAMMATION 30
268 INTERVERTEBRAL DISC PROTRUSION 30
269 LIMB DISCOMFORT 30
270 MULTIPLE SCLEROSIS 30
271 NEURALGIA 30
272 RASH PRURITIC 30
273 SINUS DISORDER 30
274 SKIN DISORDER 30
275 SKIN LESION 30
276 ARRHYTHMIA 29
277 CYSTITIS 29
278 DIPLOPIA 29
279 MENTAL IMPAIRMENT 29
280 PRODUCT DOSE OMISSION 29
281 SCAR 29
282 ACNE 28
283 ANAPHYLACTIC REACTION 28
284 DYSARTHRIA 28
285 DYSPNOEA EXERTIONAL 28
286 FOOD ALLERGY 28
287 HALLUCINATION 28
288 INCREASED APPETITE 28
289 INSURANCE ISSUE 28
290 LIMB INJURY 28
291 LIP SWELLING 28
292 MALABSORPTION 28
293 MOOD SWINGS 28
294 SKIN DISCOLOURATION 28
295 SLUGGISHNESS 28
296 THERAPY INTERRUPTED 28
297 THINKING ABNORMAL 28
298 UNDERDOSE 28
299 BLOOD CREATININE INCREASED 27
300 BLOOD POTASSIUM DECREASED 27
301 BRAIN FOG 27
302 FUNGAL INFECTION 27
303 HUNGER 27
304 LACRIMATION INCREASED 27
305 MOOD ALTERED 27
306 MUSCLE TIGHTNESS 27
307 PAIN IN JAW 27
308 PHOTOPHOBIA 27
309 RASH ERYTHEMATOUS 27
310 TEMPERATURE INTOLERANCE 27
311 APHASIA 26
312 ILL-DEFINED DISORDER 26
313 ABNORMAL BEHAVIOUR 25
314 BLINDNESS 25
315 BLOOD GLUCOSE DECREASED 25
316 CELLULITIS 25
317 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25
318 COLD SWEAT 25
319 DEVICE MALFUNCTION 25
320 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25
321 DYSURIA 25
322 EMOTIONAL DISORDER 25
323 EYE DISORDER 25
324 GASTROENTERITIS VIRAL 25
325 INJECTION SITE REACTION 25
326 NIGHTMARE 25
327 ORAL PAIN 25
328 PSORIATIC ARTHROPATHY 25
329 THYROID CANCER 25
330 TOXICITY TO VARIOUS AGENTS 25
331 VIRAL INFECTION 25
332 AGEUSIA 24
333 ANHEDONIA 24
334 AUTOIMMUNE DISORDER 24
335 CARDIAC FAILURE 24
336 DISABILITY 24
337 DYSKINESIA 24
338 GLYCOSYLATED HAEMOGLOBIN INCREASED 24
339 INFUSION SITE PAIN 24
340 INJECTION SITE HAEMORRHAGE 24
341 IRRITABLE BOWEL SYNDROME 24
342 LYME DISEASE 24
343 MUCOSAL INFLAMMATION 24
344 ALLERGIC REACTION TO EXCIPIENT 23
345 BODY HEIGHT DECREASED 23
346 CARDIAC FAILURE CONGESTIVE 23
347 COMPLETED SUICIDE 23
348 CONVULSION 23
349 HYPOACUSIS 23
350 LYMPHADENOPATHY 23
351 MULTIPLE ALLERGIES 23
352 NEEDLE ISSUE 23
353 OSTEONECROSIS 23
354 OSTEOPENIA 23
355 THERAPY CESSATION 23
356 BACK DISORDER 22
357 BLOOD PRESSURE FLUCTUATION 22
358 DERMATITIS CONTACT 22
359 FREQUENT BOWEL MOVEMENTS 22
360 GASTRIC DISORDER 22
361 IMPAIRED WORK ABILITY 22
362 INSULIN-LIKE GROWTH FACTOR INCREASED 22
363 NEOPLASM MALIGNANT 22
364 NERVE COMPRESSION 22
365 NERVOUS SYSTEM DISORDER 22
366 ONYCHOCLASIS 22
367 PRODUCT TASTE ABNORMAL 22
368 RED BLOOD CELL COUNT DECREASED 22
369 STAPHYLOCOCCAL INFECTION 22
370 ADRENAL INSUFFICIENCY 21
371 AGGRESSION 21
372 BODY TEMPERATURE DECREASED 21
373 BONE DISORDER 21
374 DISORIENTATION 21
375 FOOT FRACTURE 21
376 HAIR TEXTURE ABNORMAL 21
377 INTENTIONAL DOSE OMISSION 21
378 JOINT INJURY 21
379 MOVEMENT DISORDER 21
380 OBESITY 21
381 PERIPHERAL COLDNESS 21
382 PLEURAL EFFUSION 21
383 PRESCRIBED OVERDOSE 21
384 PRODUCT PHYSICAL ISSUE 21
385 RESTLESS LEGS SYNDROME 21
386 SYSTEMIC LUPUS ERYTHEMATOSUS 21
387 THYROXINE DECREASED 21
388 WEIGHT FLUCTUATION 21
389 ARTHROPATHY 20
390 ASPARTATE AMINOTRANSFERASE INCREASED 20
391 BLOOD PRESSURE ABNORMAL 20
392 COLITIS ULCERATIVE 20
393 CORONARY ARTERY DISEASE 20
394 DRUG EFFECT INCOMPLETE 20
395 FEAR 20
396 GLOMERULAR FILTRATION RATE DECREASED 20
397 HYPOPHAGIA 20
398 INJECTION SITE MASS 20
399 INTERVERTEBRAL DISC DEGENERATION 20
400 LIVER FUNCTION TEST ABNORMAL 20
401 PARAESTHESIA ORAL 20
402 POOR QUALITY SLEEP 20
403 RESPIRATORY TRACT INFECTION 20
404 RESTLESSNESS 20
405 RIB FRACTURE 20
406 SKIN BURNING SENSATION 20
407 THERAPEUTIC RESPONSE DECREASED 20
408 VISUAL ACUITY REDUCED 20
409 VITAMIN D DECREASED 20
410 ACCIDENTAL EXPOSURE TO PRODUCT 19
411 BIPOLAR DISORDER 19
412 CARDIAC ARREST 19
413 DIVERTICULITIS 19
414 EXTRA DOSE ADMINISTERED 19
415 GASTRITIS 19
416 GLUTEN SENSITIVITY 19
417 HAEMATOCHEZIA 19
418 JOINT STIFFNESS 19
419 MAJOR DEPRESSION 19
420 MANIA 19
421 MUSCLE TWITCHING 19
422 PANCREATITIS 19
423 PRODUCT ODOUR ABNORMAL 19
424 PRURITUS GENERALISED 19
425 TOOTH INFECTION 19
426 ARTHROPOD BITE 18
427 CHOKING 18
428 CHROMATURIA 18
429 CROHN^S DISEASE 18
430 DISEASE PROGRESSION 18
431 EAR DISCOMFORT 18
432 ENERGY INCREASED 18
433 ERUCTATION 18
434 GOITRE 18
435 IMPAIRED HEALING 18
436 LOWER RESPIRATORY TRACT INFECTION 18
437 MADAROSIS 18
438 MIDDLE INSOMNIA 18
439 MUSCULOSKELETAL DISCOMFORT 18
440 PARANOIA 18
441 PLATELET COUNT DECREASED 18
442 PROCEDURAL PAIN 18
443 SINUS CONGESTION 18
444 SKIN FISSURES 18
445 SKIN HAEMORRHAGE 18
446 THERAPEUTIC RESPONSE SHORTENED 18
447 THERAPY NON-RESPONDER 18
448 THIRST 18
449 TONGUE DISCOLOURATION 18
450 URINARY INCONTINENCE 18
451 BLOOD SODIUM DECREASED 17
452 BLOOD TRIGLYCERIDES INCREASED 17
453 BODY TEMPERATURE INCREASED 17
454 DRUG ABUSE 17
455 DRUG ADMINISTRATION ERROR 17
456 EXPIRED PRODUCT ADMINISTERED 17
457 EXPOSURE DURING PREGNANCY 17
458 HEAD DISCOMFORT 17
459 HYPOCALCAEMIA 17
460 HYPOKALAEMIA 17
461 INFUSION SITE PRURITUS 17
462 INFUSION SITE SWELLING 17
463 INTESTINAL OBSTRUCTION 17
464 LOCAL SWELLING 17
465 LOWER LIMB FRACTURE 17
466 PRESYNCOPE 17
467 RASH MACULAR 17
468 RETCHING 17
469 SUICIDE ATTEMPT 17
470 TRANSIENT ISCHAEMIC ATTACK 17
471 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17
472 APHONIA 16
473 BACK INJURY 16
474 BRADYCARDIA 16
475 CARDIOMYOPATHY 16
476 COLITIS 16
477 DIABETES MELLITUS INADEQUATE CONTROL 16
478 EYE PRURITUS 16
479 GASTROINTESTINAL HAEMORRHAGE 16
480 GOUT 16
481 HAEMATOCRIT DECREASED 16
482 INFUSION SITE ERYTHEMA 16
483 LIGAMENT SPRAIN 16
484 MULTIPLE SCLEROSIS RELAPSE 16
485 ORAL DISCOMFORT 16
486 ORAL HERPES 16
487 ORTHOSTATIC HYPOTENSION 16
488 PAIN OF SKIN 16
489 PHARYNGEAL OEDEMA 16
490 POOR QUALITY PRODUCT ADMINISTERED 16
491 POOR VENOUS ACCESS 16
492 PRODUCT AVAILABILITY ISSUE 16
493 PRODUCT DOSE OMISSION IN ERROR 16
494 RENAL IMPAIRMENT 16
495 SPINAL OPERATION 16
496 THYROIDECTOMY 16
497 TYPE 2 DIABETES MELLITUS 16
498 WOUND COMPLICATION 16
499 ABASIA 15
500 BEDRIDDEN 15
501 CANDIDA INFECTION 15
502 CHOLECYSTECTOMY 15
503 CHOLELITHIASIS 15
504 FEEDING DISORDER 15
505 GLOSSODYNIA 15
506 HAEMORRHOIDS 15
507 IMPAIRED DRIVING ABILITY 15
508 INJECTION SITE RASH 15
509 INJECTION SITE URTICARIA 15
510 MUSCLE STRAIN 15
511 PHARMACEUTICAL PRODUCT COMPLAINT 15
512 PHARYNGITIS 15
513 PSYCHOTIC DISORDER 15
514 RASH GENERALISED 15
515 ROTATOR CUFF SYNDROME 15
516 SCIATICA 15
517 SECRETION DISCHARGE 15
518 TARDIVE DYSKINESIA 15
519 TOOTH ABSCESS 15
520 VAGINAL HAEMORRHAGE 15
521 VENTRICULAR EXTRASYSTOLES 15
522 VITAMIN D DEFICIENCY 15
523 WHITE BLOOD CELL COUNT INCREASED 15
524 ABDOMINAL PAIN LOWER 14
525 ACCIDENTAL OVERDOSE 14
526 ANGIOEDEMA 14
527 CONCUSSION 14
528 DERMATITIS ATOPIC 14
529 DEVICE LEAKAGE 14
530 DRUG DEPENDENCE 14
531 DRUG DISPENSING ERROR 14
532 DRY THROAT 14
533 EXPOSURE VIA SKIN CONTACT 14
534 FOREIGN BODY SENSATION IN EYES 14
535 HEPATIC STEATOSIS 14
536 HIP FRACTURE 14
537 HYPERGLYCAEMIA 14
538 HYPONATRAEMIA 14
539 IMMUNE SYSTEM DISORDER 14
540 KIDNEY INFECTION 14
541 LIVER DISORDER 14
542 MALIGNANT NEOPLASM PROGRESSION 14
543 MALNUTRITION 14
544 MEDICATION ERROR 14
545 MICTURITION URGENCY 14
546 MOUTH ULCERATION 14
547 OCULAR DISCOMFORT 14
548 OSTEOMYELITIS 14
549 OVARIAN CYST 14
550 POST PROCEDURAL COMPLICATION 14
551 PRODUCT USE COMPLAINT 14
552 RESPIRATORY TRACT CONGESTION 14
553 SKIN LACERATION 14
554 TRI-IODOTHYRONINE ABNORMAL 14
555 ULCER 14
556 URINARY RETENTION 14
557 ABORTION SPONTANEOUS 13
558 ALANINE AMINOTRANSFERASE INCREASED 13
559 ANKLE FRACTURE 13
560 APPLICATION SITE ERYTHEMA 13
561 CARDIAC FLUTTER 13
562 CARDIAC MURMUR 13
563 COMA 13
564 DEAFNESS 13
565 DECREASED ACTIVITY 13
566 DEPRESSED LEVEL OF CONSCIOUSNESS 13
567 DRUG EFFECT LESS THAN EXPECTED 13
568 FOOD CRAVING 13
569 GAIT INABILITY 13
570 GALLBLADDER DISORDER 13
571 GENERALISED OEDEMA 13
572 GLAUCOMA 13
573 HORMONE LEVEL ABNORMAL 13
574 HYPERLIPIDAEMIA 13
575 HYPOPHOSPHATAEMIA 13
576 IMPAIRED GASTRIC EMPTYING 13
577 LUNG DISORDER 13
578 MUSCULOSKELETAL CHEST PAIN 13
579 PAPILLARY THYROID CANCER 13
580 PULMONARY OEDEMA 13
581 RASH PAPULAR 13
582 RECALLED PRODUCT 13
583 RESPIRATORY FAILURE 13
584 SCOLIOSIS 13
585 SENSATION OF FOREIGN BODY 13
586 SENSORY DISTURBANCE 13
587 SKIN IRRITATION 13
588 SPUTUM DISCOLOURED 13
589 TOOTHACHE 13
590 UPPER LIMB FRACTURE 13
591 WRIST FRACTURE 13
592 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13
593 AFFECTIVE DISORDER 12
594 APPETITE DISORDER 12
595 BLOOD TESTOSTERONE DECREASED 12
596 BLOOD URINE PRESENT 12
597 BURSITIS 12
598 DELUSION 12
599 ECONOMIC PROBLEM 12
600 FEBRILE NEUTROPENIA 12
601 FEMUR FRACTURE 12
602 FRUSTRATION TOLERANCE DECREASED 12
603 GASTROENTERITIS 12
604 HAIR DISORDER 12
605 HANGOVER 12
606 HEPATITIS 12
607 HERNIA 12
608 HYPOKINESIA 12
609 IMMUNOGLOBULINS DECREASED 12
610 IMPAIRED QUALITY OF LIFE 12
611 IRON DEFICIENCY ANAEMIA 12
612 KNEE ARTHROPLASTY 12
613 LARYNGITIS 12
614 MASS 12
615 MATERNAL EXPOSURE DURING PREGNANCY 12
616 MENORRHAGIA 12
617 MUSCLE ATROPHY 12
618 MYOSITIS 12
619 NASAL DRYNESS 12
620 NERVE INJURY 12
621 NOCTURIA 12
622 OBSESSIVE-COMPULSIVE DISORDER 12
623 PHARYNGEAL SWELLING 12
624 POLYCYSTIC OVARIAN SYNDROME 12
625 POST-TRAUMATIC STRESS DISORDER 12
626 PRODUCT PRESCRIBING ERROR 12
627 RECTAL HAEMORRHAGE 12
628 SKIN ULCER 12
629 SOMNAMBULISM 12
630 SPINAL FRACTURE 12
631 TASTE DISORDER 12
632 TOOTH DISORDER 12
633 TREATMENT FAILURE 12
634 URINE ODOUR ABNORMAL 12
635 UTERINE LEIOMYOMA 12
636 ADRENAL DISORDER 11
637 BLOOD CALCIUM INCREASED 11
638 BLOOD POTASSIUM INCREASED 11
639 BLOOD PRESSURE DIASTOLIC DECREASED 11
640 BLOOD UREA INCREASED 11
641 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11
642 CLUMSINESS 11
643 DERMATITIS 11
644 DIABETIC KETOACIDOSIS 11
645 DIABETIC NEUROPATHY 11
646 DIZZINESS POSTURAL 11
647 HAEMOPTYSIS 11
648 HAIR COLOUR CHANGES 11
649 HYPERKERATOSIS 11
650 HYPOXIA 11
651 INITIAL INSOMNIA 11
652 INTERNATIONAL NORMALISED RATIO INCREASED 11
653 INTERVERTEBRAL DISC DISORDER 11
654 LOCALISED INFECTION 11
655 LUMBAR SPINAL STENOSIS 11
656 MENSTRUAL DISORDER 11
657 NAIL DISORDER 11
658 OSTEONECROSIS OF JAW 11
659 PALLOR 11
660 PERSONALITY CHANGE 11
661 PHARYNGITIS STREPTOCOCCAL 11
662 PNEUMONIA ASPIRATION 11
663 PRODUCT FORMULATION ISSUE 11
664 PULMONARY HYPERTENSION 11
665 SINUS HEADACHE 11
666 SNEEZING 11
667 SNORING 11
668 SPINAL OSTEOARTHRITIS 11
669 SUBCUTANEOUS EMPHYSEMA 11
670 THYROXINE ABNORMAL 11
671 TOOTH EXTRACTION 11
672 ABNORMAL FAECES 10
673 ADDISON^S DISEASE 10
674 AFFECT LABILITY 10
675 BLOOD ALKALINE PHOSPHATASE INCREASED 10
676 BLOOD CALCIUM DECREASED 10
677 BLOOD IRON DECREASED 10
678 BRAIN INJURY 10
679 CLOSTRIDIUM DIFFICILE INFECTION 10
680 DEVICE DISLOCATION 10
681 DEVICE RELATED INFECTION 10
682 DYSMENORRHOEA 10
683 EXOSTOSIS 10
684 FEELING OF BODY TEMPERATURE CHANGE 10
685 GINGIVAL BLEEDING 10
686 HEREDITARY ANGIOEDEMA 10
687 HIP ARTHROPLASTY 10
688 HYPERCALCAEMIA 10
689 HYPOAESTHESIA ORAL 10
690 INCOHERENT 10
691 INCORRECT ROUTE OF DRUG ADMINISTRATION 10
692 INCREASED TENDENCY TO BRUISE 10
693 INFUSION SITE EXTRAVASATION 10
694 INTENTIONAL OVERDOSE 10
695 INTERSTITIAL LUNG DISEASE 10
696 LARGE INTESTINE POLYP 10
697 LICHEN SCLEROSUS 10
698 LYMPHOCYTE COUNT DECREASED 10
699 MENSTRUATION IRREGULAR 10
700 MYDRIASIS 10
701 NEOPLASM PROGRESSION 10
702 PERICARDIAL EFFUSION 10
703 PHOTOSENSITIVITY REACTION 10
704 PRODUCT PREPARATION ERROR 10
705 QUALITY OF LIFE DECREASED 10
706 RESPIRATORY DISORDER 10
707 ROSACEA 10
708 SINUS TACHYCARDIA 10
709 SJOGREN^S SYNDROME 10
710 SKIN CANCER 10
711 SMALL INTESTINAL OBSTRUCTION 10
712 STRABISMUS 10
713 THYROID HORMONES DECREASED 10
714 THYROXINE FREE DECREASED 10
715 WEIGHT LOSS POOR 10
716 WOUND 10
717 ANIMAL BITE 9
718 ANOSMIA 9
719 ANTIBODY TEST ABNORMAL 9
720 APATHY 9
721 APPLICATION SITE PRURITUS 9
722 BLOOD MAGNESIUM DECREASED 9
723 BLOOD PRESSURE SYSTOLIC INCREASED 9
724 BREAST PAIN 9
725 BRUXISM 9
726 CARDIAC FAILURE ACUTE 9
727 CARDIOMEGALY 9
728 CHRONIC SINUSITIS 9
729 COMPLEX REGIONAL PAIN SYNDROME 9
730 DIFFUSE VASCULITIS 9
731 DISSOCIATION 9
732 EXERCISE TOLERANCE DECREASED 9
733 FOOT DEFORMITY 9
734 GASTRIC ULCER 9
735 GASTROINTESTINAL PAIN 9
736 GLUCOSE TOLERANCE IMPAIRED 9
737 HALLUCINATION, AUDITORY 9
738 HERPES VIRUS INFECTION 9
739 HIATUS HERNIA 9
740 HYPERACUSIS 9
741 HYPERAESTHESIA 9
742 INFUSION SITE BRUISING 9
743 INJECTION SITE DISCOMFORT 9
744 INTENTIONAL DRUG MISUSE 9
745 INTRAOCULAR PRESSURE INCREASED 9
746 JOINT RANGE OF MOTION DECREASED 9
747 LIGAMENT RUPTURE 9
748 MENISCUS INJURY 9
749 MITRAL VALVE INCOMPETENCE 9
750 MUSCLE DISORDER 9
751 MUSCLE SPASTICITY 9
752 MYASTHENIA GRAVIS 9
753 NEPHROGENIC ANAEMIA 9
754 OROPHARYNGEAL DISCOMFORT 9
755 PEAK EXPIRATORY FLOW RATE DECREASED 9
756 PERFORATION 9
757 PERIORBITAL OEDEMA 9
758 PHOTOPSIA 9
759 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 9
760 PRODUCT ADMINISTRATION ERROR 9
761 PRODUCT COMPLAINT 9
762 PRODUCT DISTRIBUTION ISSUE 9
763 PRODUCT STORAGE ERROR 9
764 RENAL INJURY 9
765 RESPIRATORY SYMPTOM 9
766 SEROTONIN SYNDROME 9
767 SUSPECTED COUNTERFEIT PRODUCT 9
768 TEARFULNESS 9
769 THERAPEUTIC RESPONSE CHANGED 9
770 TOOTH FRACTURE 9
771 TRICHORRHEXIS 9
772 VAGINAL INFECTION 9
773 WALKING AID USER 9
774 WRONG DRUG ADMINISTERED 9
775 ACUTE SINUSITIS 8
776 ADRENOCORTICAL INSUFFICIENCY ACUTE 8
777 AMENORRHOEA 8
778 BACTERIAL INFECTION 8
779 BASAL CELL CARCINOMA 8
780 BLINDNESS UNILATERAL 8
781 BLOOD IMMUNOGLOBULIN G DECREASED 8
782 BREAST CANCER FEMALE 8
783 BRONCHOSPASM 8
784 C-REACTIVE PROTEIN INCREASED 8
785 CHOLECYSTITIS INFECTIVE 8
786 COAGULOPATHY 8
787 COORDINATION ABNORMAL 8
788 DEAFNESS NEUROSENSORY 8
789 DENTAL CARIES 8
790 DEVICE BREAKAGE 8
791 DRUG TOLERANCE 8
792 ERECTILE DYSFUNCTION 8
793 ESSENTIAL HYPERTENSION 8
794 EUPHORIC MOOD 8
795 EYE INFLAMMATION 8
796 FACE OEDEMA 8
797 FACIAL PAIN 8
798 FAECES SOFT 8
799 FRACTURE 8
800 GROIN PAIN 8
801 HEMIPARESIS 8
802 HYPERCHOLESTEROLAEMIA 8
803 HYPERKALAEMIA 8
804 HYSTERECTOMY 8
805 INCORRECT PRODUCT ADMINISTRATION DURATION 8
806 INFUSION SITE DISCHARGE 8
807 LOW DENSITY LIPOPROTEIN INCREASED 8
808 MENOPAUSE 8
809 MUCOSAL ULCERATION 8
810 NODULE 8
811 OBSTRUCTION 8
812 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8
813 PERIARTHRITIS 8
814 PHYSICAL DISABILITY 8
815 POST PROCEDURAL HYPOTHYROIDISM 8
816 POSTMENOPAUSAL HAEMORRHAGE 8
817 PROTEIN URINE PRESENT 8
818 RENAL FAILURE ACUTE 8
819 RESPIRATORY DISTRESS 8
820 SKIN REACTION 8
821 SPINAL COLUMN STENOSIS 8
822 SPINAL COMPRESSION FRACTURE 8
823 SPINAL DISORDER 8
824 SPINAL FUSION SURGERY 8
825 SPONDYLOLISTHESIS 8
826 SUPRAVENTRICULAR TACHYCARDIA 8
827 THERMAL BURN 8
828 THYROXINE INCREASED 8
829 TYPE V HYPERLIPIDAEMIA 8
830 UPPER-AIRWAY COUGH SYNDROME 8
831 URINE OUTPUT DECREASED 8
832 VENTRICULAR FIBRILLATION 8
833 ABSCESS 7
834 AKATHISIA 7
835 ANOREXIA 7
836 ANXIETY DISORDER 7
837 ATELECTASIS 7
838 ATRIAL FLUTTER 7
839 BASEDOW^S DISEASE 7
840 BLADDER DISORDER 7
841 BLEPHAROSPASM 7
842 BLOOD CHLORIDE INCREASED 7
843 BLOOD GLUCOSE ABNORMAL 7
844 BLOOD PHOSPHORUS DECREASED 7
845 BONE DENSITY DECREASED 7
846 BREAST TENDERNESS 7
847 CAESAREAN SECTION 7
848 CEREBRAL HAEMORRHAGE 7
849 CONJUNCTIVITIS 7
850 DELIRIUM 7
851 DERMATITIS ALLERGIC 7
852 DEVICE USE ISSUE 7
853 DYSPHEMIA 7
854 END STAGE RENAL DISEASE 7
855 ENDOCRINE OPHTHALMOPATHY 7
856 EPSTEIN-BARR VIRUS INFECTION 7
857 ERYTHEMA OF EYELID 7
858 EXPIRED DRUG ADMINISTERED 7
859 EYE DISCHARGE 7
860 EYE HAEMORRHAGE 7
861 EYE INFECTION 7
862 FORMICATION 7
863 FULL BLOOD COUNT DECREASED 7
864 GASTRIC DILATATION 7
865 HAEMATOMA 7
866 HAEMATURIA 7
867 HAIR GROWTH ABNORMAL 7
868 HAND FRACTURE 7
869 HEART RATE ABNORMAL 7
870 HYPERVENTILATION 7
871 INCONTINENCE 7
872 INCORRECT DRUG ADMINISTRATION RATE 7
873 INFUSION SITE HAEMORRHAGE 7
874 INHIBITORY DRUG INTERACTION 7
875 JOINT EFFUSION 7
876 KNEE OPERATION 7
877 LIBIDO DECREASED 7
878 LIMB OPERATION 7
879 LOGORRHOEA 7
880 LOSS OF EMPLOYMENT 7
881 MATERNAL EXPOSURE DURING BREAST FEEDING 7
882 MENOPAUSAL SYMPTOMS 7
883 MENTAL STATUS CHANGES 7
884 METABOLIC DISORDER 7
885 METASTASES TO LYMPH NODES 7
886 MITRAL VALVE PROLAPSE 7
887 MUSCULOSKELETAL DISORDER 7
888 NASAL DISCOMFORT 7
889 NECK INJURY 7
890 ONYCHOMYCOSIS 7
891 ORAL CANDIDIASIS 7
892 ORAL DISORDER 7
893 PANCREATIC DISORDER 7
894 PANIC REACTION 7
895 PARALYSIS 7
896 PRE-ECLAMPSIA 7
897 PREGNANCY 7
898 PRESCRIBED UNDERDOSE 7
899 PRODUCT COLOUR ISSUE 7
900 PRODUCT PHYSICAL CONSISTENCY ISSUE 7
901 PRODUCT SUPPLY ISSUE 7
902 PSEUDOMONAS INFECTION 7
903 PSYCHOLOGICAL TRAUMA 7
904 PULSE ABNORMAL 7
905 RAYNAUD^S PHENOMENON 7
906 REBOUND EFFECT 7
907 RENAL CYST 7
908 RENAL PAIN 7
909 RHINITIS 7
910 SEPTIC SHOCK 7
911 SKIN INFECTION 7
912 SKIN PAPILLOMA 7
913 SKIN SWELLING 7
914 STRESS FRACTURE 7
915 SUSPECTED PRODUCT QUALITY ISSUE 7
916 SYNOVITIS 7
917 TENDON DISORDER 7
918 TENDON PAIN 7
919 THROMBOCYTOPENIA 7
920 TRICUSPID VALVE INCOMPETENCE 7
921 VENTRICULAR TACHYCARDIA 7
922 WOUND INFECTION 7
923 WRONG DOSE 7
924 ACUTE MYOCARDIAL INFARCTION 6
925 ANAEMIA OF CHRONIC DISEASE 6
926 ANGINA PECTORIS 6
927 ANTI-THYROID ANTIBODY POSITIVE 6
928 ANTINUCLEAR ANTIBODY POSITIVE 6
929 APPENDICECTOMY 6
930 ARTERIOSCLEROSIS CORONARY ARTERY 6
931 ASCITES 6
932 AUTONOMIC NERVOUS SYSTEM IMBALANCE 6
933 BIPOLAR I DISORDER 6
934 BLEPHARITIS 6
935 BLOOD CREATINE PHOSPHOKINASE INCREASED 6
936 BLOOD PROLACTIN DECREASED 6
937 BLOOD TESTOSTERONE INCREASED 6
938 BODY TEMPERATURE FLUCTUATION 6
939 BOWEL MOVEMENT IRREGULARITY 6
940 CANDIDIASIS 6
941 CARTILAGE INJURY 6
942 CENTRAL NERVOUS SYSTEM LESION 6
943 CHALAZION 6
944 CHOLECYSTITIS CHRONIC 6
945 CHRONIC FATIGUE SYNDROME 6
946 CONCOMITANT DISEASE AGGRAVATED 6
947 CONNECTIVE TISSUE DISORDER 6
948 DEAFNESS UNILATERAL 6
949 DEFORMITY 6
950 DEMENTIA 6
951 DRUG EFFECT INCREASED 6
952 DRUG EXPOSURE DURING PREGNANCY 6
953 DYSGRAPHIA 6
954 EJECTION FRACTION DECREASED 6
955 ENDOMETRIOSIS 6
956 ENURESIS 6
957 FEELING DRUNK 6
958 GASTROINTESTINAL INFLAMMATION 6
959 GASTROINTESTINAL MOTILITY DISORDER 6
960 GASTROINTESTINAL SOUNDS ABNORMAL 6
961 GENERALISED TONIC-CLONIC SEIZURE 6
962 GRAVES^ DISEASE 6
963 HALLUCINATION, VISUAL 6
964 HYPOGONADISM 6
965 IDIOPATHIC INTRACRANIAL HYPERTENSION 6
966 IMMUNODEFICIENCY 6
967 IMPAIRED SELF-CARE 6
968 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6
969 INJECTION SITE WARMTH 6
970 INSULIN RESISTANCE 6
971 JUDGEMENT IMPAIRED 6
972 LEUKOPENIA 6
973 LIVER FUNCTION TEST INCREASED 6
974 LOSS OF LIBIDO 6
975 METASTASES TO LUNG 6
976 MORNING SICKNESS 6
977 MYOPATHY 6
978 NEUTROPHIL COUNT INCREASED 6
979 OCULAR ICTERUS 6
980 PANCREATITIS ACUTE 6
981 PANCYTOPENIA 6
982 PANIC DISORDER 6
983 PARTIAL SEIZURES 6
984 PELVIC PAIN 6
985 PERIORBITAL SWELLING 6
986 PLEURISY 6
987 PNEUMOTHORAX 6
988 POLYP 6
989 POOR QUALITY DRUG ADMINISTERED 6
990 POST PROCEDURAL INFECTION 6
991 PREMATURE MENOPAUSE 6
992 PRODUCT ADHESION ISSUE 6
993 PRODUCT PACKAGING ISSUE 6
994 PRODUCT PRESCRIBING ISSUE 6
995 PRODUCT SIZE ISSUE 6
996 PSYCHOMOTOR RETARDATION 6
997 PULMONARY CONGESTION 6
998 PULMONARY MASS 6
999 RASH MACULO-PAPULAR 6